IN2013MU00646A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00646A
IN2013MU00646A IN646MU2013A IN2013MU00646A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A IN 646MU2013 A IN646MU2013 A IN 646MU2013A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A
Authority
IN
India
Prior art keywords
preparation
present
crystalline form
provides novel
endoxifen
Prior art date
Application number
Other languages
English (en)
Inventor
Jagdish Desai Sanjay
Dinkarrai Desai Brijesh
Viththal Guna Jayesh
Chandulal Patel Sunil
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to IN646MU2013 priority Critical patent/IN2013MU00646A/en
Priority to PCT/IN2014/000136 priority patent/WO2014141292A2/en
Publication of IN2013MU00646A publication Critical patent/IN2013MU00646A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN646MU2013 2013-03-04 2014-03-03 IN2013MU00646A (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN646MU2013 IN2013MU00646A (tr) 2013-03-04 2014-03-03
PCT/IN2014/000136 WO2014141292A2 (en) 2013-03-04 2014-03-03 Endoxifen citrate polymorph and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN646MU2013 IN2013MU00646A (tr) 2013-03-04 2014-03-03

Publications (1)

Publication Number Publication Date
IN2013MU00646A true IN2013MU00646A (tr) 2015-06-26

Family

ID=51538243

Family Applications (1)

Application Number Title Priority Date Filing Date
IN646MU2013 IN2013MU00646A (tr) 2013-03-04 2014-03-03

Country Status (2)

Country Link
IN (1) IN2013MU00646A (tr)
WO (1) WO2014141292A2 (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107406457B (zh) 2015-06-16 2019-02-01 江苏恒瑞医药股份有限公司 哌啶类衍生物、其制备方法及其在医药上的应用
JP2019503346A (ja) 2015-12-22 2019-02-07 ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． ベンゾピペリジン誘導体、その製造方法及びその医薬用途
CN116832020A (zh) * 2017-09-11 2023-10-03 阿托萨治疗学公司 制备和使用内昔芬的方法
JP7113542B2 (ja) 2017-11-14 2022-08-05 カインド ファーマシューティカル 複素環式化合物及びその医学的応用
BR112022013322A2 (pt) 2020-01-10 2022-09-20 Jiangsu Hengrui Medicine Co Derivado de tetra-hidroisoquinolina tricíclico, método de preparação para o mesmo e aplicação do mesmo em medicina
WO2021205402A1 (en) * 2020-04-10 2021-10-14 Jina Pharmaceuticals, Inc. Endoxifen for the treatment of bipolar i disorder
CA3177266A1 (en) * 2020-04-10 2021-10-14 Jina Pharmaceuticals, Inc. Endoxifen for the treatment of bipolar i disorder
CN117642405A (zh) 2021-07-09 2024-03-01 江苏恒瑞医药股份有限公司 一种三环四氢异喹啉类衍生物的盐型
WO2023137044A2 (en) 2022-01-12 2023-07-20 Atossa Therapeutics, Inc. Compositions of (z)-endoxifen and methods of enrichment thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
US20090291134A1 (en) * 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
WO2009120999A2 (en) * 2008-03-28 2009-10-01 Olema Pharmaceuticals, Inc. Use of an endoxifen prodrug for treatment of breast cancer
KR101308258B1 (ko) * 2010-10-15 2013-09-13 씨제이제일제당 (주) 엔독시펜의 신규한 제조 방법

Also Published As

Publication number Publication date
WO2014141292A3 (en) 2014-12-24
WO2014141292A2 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
IN2013MU00646A (tr)
IN2014CH00247A (tr)
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2013MU00848A (tr)
IL249872A0 (en) Amorphous form of eliglostat hemetrate, preparations containing it and methods for its preparation
IL245474B (en) Process for preparing 5-fluoro-1h-pyrazoles
IN2014MU00455A (tr)
IL245476A0 (en) Process for preparing 5-fluoro-1h-pyrazoles
IN2013MU03070A (tr)
EP3016935A4 (en) Process for the preparation of intermediate of dolutegravir
MX2016015465A (es) Composicion farmaceutica oral de isotretinoina.
IN2013MU01113A (tr)
PL2964607T3 (pl) Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin
IL229326A (en) Process for making n-iodine-affluent
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
WO2014170909A3 (en) Process for pomalidomide
IN2013MU02528A (tr)
MX2016005146A (es) Metodo para producir halocetonas.
IN2014CH01391A (tr)
IN2013MU03768A (tr)
IN2013MU01501A (tr)
IN2013CH05395A (tr)
IL246188A0 (en) A process for the preparation of tiacomycin